The toxicity of hexanedione isomers in neural and astrocytic cell lines

Environmental Toxicology and Pharmacology

Volumn 22, Issue 3, 2006, Pages 249-254

  Woehrling, Elizabeth K ^a   Zilz, Thomas R ^a   Coleman, Michael D ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Astrocytic; CCF STTG1; Hexanedione; Neural; NT2.N; SK N SH

Indexed keywords

2,3 HEXANEDIONE; 3,4 HEXANEDIONE; ACETONYLACETONE; HEXANE; KETONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL LINE; CYTOTOXICITY; HUMAN; HUMAN CELL; NERVE CELL; NEUROTOXICITY; PRIORITY JOURNAL;

EID: 33748987050     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2005.12.010     Document Type: Article

References (34)

1. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103 (1984) 285-293
2. Andrews P.W., Damjanov I., Simon D., Carlin C., Dracopoli N., and Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line TERA-2. Lab. Invest. 50 (1984) 147-162
3. Barna B.P., Chou S.M., Jacobs B., Raushoff R.M., Hahn J.F., and Bay J.W. Enhanced DNA synthesis of human glial cells exposed to human leukocyte products. J. Neuroimmunol. 10 (1985) 151-158
4. Biedler J.L., Helson L., and Spengler B.A. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33 (1973) 2643-2652
5. Biedler J.L., Roffler-Tarlov S., Schachner M., and Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38 (1978) 3751-3757
6. Boegner F., Grüning W., Stoltenburg-Didnger G., Marx P., and Atenkirch H. 2,5-hexanedione is a potent gliatoxin in in vitro cell cultures of the nervous system. NeuroToxicology 13 (1992) 151-154
7. Coll O., Colell A., Garcia-Ruiz C., Kaplowitz N., and Fernandez-Checa J.C. Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion. Hepatology 38 (2003) 692-702
8. Couri D., Abdel-Rahman M.S., and Hetland L.B. Biotransformation of n-hexane and methyl n-butyl ketone in guinea pigs and mice. Am. Ind. Hyg. Assoc. J. 39 (1978) 295-300
9. DeCaprio A.P., and O'Neill E.A. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. Toxicol. Appl. Pharmacol. 78 (1985) 235-247
10. DeCaprio A.P. n-Hexane neurotoxicity: a mechanism involving pyrrole adduct formation in axonal cytoskeletal protein. NeuroToxicology 8 (1987) 199-210
11. DeCaprio A.P., Briggs R.G., Jackowski S.J., and Kim J.C.S. Comparative neurotoxicity and pyrrole-forming proteins of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat. Toxicol. Appl. Pharmacol. 92 (1988) 75-85
12. DeCaprio A.P., Kinney E.A., and Fowke J.H. Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro. Toxicol. Appl. Pharmacol. 145 (1997) 211-217
13. Durham H.D. Aggregation of intermediate filaments by 2,5-hexanedione: comparison of effects on neurofilaments, GFAP-filaments and vimentin-filaments in dissociated cultures of mouse spinal cord-dorsal root ganglia. J. Neuropathol. Exp. Neurol. 47 (1988) 432-442
14. Heijink E., Scholten S.W., Bolhuis P.A., and de Wolff F.A. Effects of 2,5-hexanedione on calpain-mediated degradation of human neurofilaments in vitro. Chem-Biol. Interact. 129 (2000) 231-247
15. Iwasaki K., and Tsuruta H. Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4- and 2.5-hexanedione. Ind. Health 22 (1984) 177-187
16. Joint FAO/WHO. Expert Committee on Food Additives, 51st Meeting. Geneva, June 9-18 (1998)
17. Lash L.H., Putt D.A., and Matherly L.H. Protection of NRK-52E cells, a rat renal proximal tubular cell line, from chemical-induced apoptosis by overexpression of a mitochondrial glutathione transporter. J. Pharmacol. Exp. Ther. 303 (2002) 476-486
18. Lee V.M.Y., and Andrews P.W. Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J. Neurosci. 6 (1986) 514-521
19. LoPachin R.M., and Aschner M. Contemporary issues in toxicology: glial-neuronal interactions: relevance to neurotoxic mechanisms. Toxicol. Appl. Pharmcol. 118 (1993) 141-158
20. LoPachin R.M., and Lehning E.J. The relevance of axonal swelling and atrophy to γ-diketone neurotoxicity. Neurotoxicology 18 (1997) 7-22
21. LoPachin R.M., Lehning E.J., Opanashuk L.A., and Jortner B.S. Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy. Toxicol. Appl. Pharmacol. 167 (2000) 75-86
22. LoPachin R.M., and DeCaprio A.P. γ-Diketone neuropathy: axon atrophy and role of cytoskeletal protein adduction. Toxicol. Appl. Pharmacol. 199 (2004) 20-34
23. LoPachin R.M., and DeCaprio A.P. Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol. Sci. 86 (2005) 214-225
24. Medrano C.J., and LoPachin R.M. Effects of acrylamide and 2,5-hexanedione on brain mitochondrial respiration. NeuroToxicology 10 (1989) 249-255
25. Pleasure S.J., Page C., and Lee V.M.Y. Pure, postmitotic, polarized human neurons derived from NTera2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12 (1992) 1802-1815
26. Rozman K.K., and Doull J. Dose and time as variables of toxicity. Toxicology 144 (2000) 169-178
27. Schmuck G., Ahr H.J., and Schlüter G. Rat cortical neuron cultures: an in vitro model for differentiating mechanisms of chemically induced neurotoxicity. In Vitro Mol. Toxicol. 13 (2000) 37-49
28. Selkoe D.J., Luckenbill-Edds L., and Shalanski M.L. Effects of neurotoxic industrial solvents on cultured neuroblastoma cells: methyl n-butyl ketone, n-hexane and derivatives. J. Neuropathol. Exp. Neurol. 37 (1978) 768-789
29. Sickles D.W., Fowler S.R., and Testino A.R. Effects of neurofilamentous axonopathy-producing neurotoxicants on in vitro production of ATP by brain mitochondria. Brain Res. 528 (1990) 25-31
30. Spencer P.S., Bischoff M.C., and Schaumburg H.H. On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy. Toxicol. Appl. Pharmcol. 44 (1978) 17-28
31. Stipani I., Mangiullo G., Stipani V., Daddabbo L., Natuzzi D., and Palmieri F. Inhibition of the reconstituted mitochondrial oxoglutarate carrier by arginine-specific reagents. Arch. Biochem. Biophys. 331 (1996) 48-54
32. Tada H., Shihi O., Kuroshima K., Koyama M., and Tsukamoto K. An improved colorimetric assay for interleukin 2. J. Immunol. Methods 93 (1986) 157-165
33. Tuckwell D.S., Laszlo L., and Mayer R.J. 2,5-Hexanedione-induced intermediate filament aggregates contain ubiquitin-protein conjugate immunoreactivity and resemble Rosenthal fibers. Neuropathol. Appl. Neurol. 18 (1992) 593-609
34. Zhu M., Spink D.C., Yan B., Bank S., and DeCaprio A.P. Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides and protein. Chem. Res. Toxicol. 7 (1994) 551-558